Print

Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Data Presentation at the American Society of Hematology 54th Annual Meeting and Exposition  
11/6/2012 8:43:36 AM

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced an upcoming data presentation at the American Society of Hematology 54th Annual Meeting and Exposition to be held in Atlanta, GA from December 8 through December 11, 2012. Results from a Phase 1 study of Celldex’s candidate CDX-301 will be presented in a poster session entitled “A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers” on Monday, December 10, 2012 from 6:00 pm to 8:00 pm ET.
//-->